Create safe, market leading tobacco flavoured e-liquids – engage with an expert scientific compliance team
The use of tobacco extracts and essential oils in electronic cigarette and vaping products seems counter intuitive for people trying to get away from the harmful affects of tobacco, however it is largely the combustion of tobacco that causes most of the damage rather than the flavour itself.
A number of tobacco flavours found in electronic cigarette and vaping products rely on tobacco extracts to achieve the realistic flavour profiles that customers desire. Whilst tobacco extracts are a great way of achieving a genuine flavour – their use raises unique regulatory compliance issues, which we at ADACT are perfectly suited to handle.
While tobacco extracts give an authentic flavour, one of the key issues is the presence of Tobacco-Specific Nitrosamines (TSNA) – known carcinogenic compounds found in tobacco extracts.
Some of the most carcinogenic TSNA’s include:
• Nicotine-derived nitrosamine ketone (NNK)
• N-Nitrosonornicotine (NNN)
• N-Nitrosoanatabine (NAT)
• N-Nitrosoanabasine (NAB).
Under Tobacco Products Directive (TPD), if producers wish to use tobacco extracts in their products, they must conduct testing to confirm and certify the extracts are free from carcinogenic TSNA’s.
From this initial testing, we submit test reports to the regulators to demonstrate we have tested for this, which we recommend repeating at least once a year.
There are of course many other complications with tobacco extract products, which ADACT are well suited to undertake thanks to our over 20 years’ experience of medical regulatory compliance within the pharmaceutical, biotechnology, medical devices, herbal medicines and supplements sectors.
Companies around the world have trusted ADACT with their regulatory compliance.
Please fill in the form below and our team will get back to you as soon as possible within office hours